220 related articles for article (PubMed ID: 10429540)
1. [Orlistat (Xenical)].
Crenier L; Sternon J
Rev Med Brux; 1999 Jun; 20(3):159-63. PubMed ID: 10429540
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
4. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
5. Orlistat: a review of its use in the management of obesity.
Henness S; Perry CM
Drugs; 2006; 66(12):1625-56. PubMed ID: 16956313
[TBL] [Abstract][Full Text] [Related]
6. Orlistat: a review of its use in the management of obesity.
Hvizdos KM; Markham A
Drugs; 1999 Oct; 58(4):743-60. PubMed ID: 10551441
[TBL] [Abstract][Full Text] [Related]
7. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
[TBL] [Abstract][Full Text] [Related]
8. The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes.
Nelson RH; Miles JM
Expert Opin Pharmacother; 2005 Nov; 6(14):2483-91. PubMed ID: 16259579
[TBL] [Abstract][Full Text] [Related]
9. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.
Rössner S; Sjöström L; Noack R; Meinders AE; Noseda G
Obes Res; 2000 Jan; 8(1):49-61. PubMed ID: 10678259
[TBL] [Abstract][Full Text] [Related]
10. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
Svendsen M; Helgeland M; Tonstad S
J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
[TBL] [Abstract][Full Text] [Related]
11. Orlistat (Xenical) in the management of obesity.
Cheah JS
Ann Acad Med Singap; 2000 Jul; 29(4):419-20. PubMed ID: 11056767
[No Abstract] [Full Text] [Related]
12. Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.
Tiikkainen M; Bergholm R; Rissanen A; Aro A; Salminen I; Tamminen M; Teramo K; Yki-Järvinen H
Am J Clin Nutr; 2004 Jan; 79(1):22-30. PubMed ID: 14684393
[TBL] [Abstract][Full Text] [Related]
13. Orlistat--a novel weight loss therapy.
Lucas KH; Kaplan-Machlis B
Ann Pharmacother; 2001 Mar; 35(3):314-28. PubMed ID: 11261530
[TBL] [Abstract][Full Text] [Related]
14. Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns.
Karhunen L; Franssila-Kallunki A; Rissanen P; Valve R; Kolehmainen M; Rissanen A; Uusitupa M
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1567-72. PubMed ID: 11126207
[TBL] [Abstract][Full Text] [Related]
15. Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men.
Pace DG; Blotner S; Guerciolini R
J Nutr; 2001 Jun; 131(6):1694-9. PubMed ID: 11385055
[TBL] [Abstract][Full Text] [Related]
16. [What is the evidence with regard to the effectiveness of orlistat?].
Nordmann A
Schweiz Med Wochenschr; 2000 Apr; 130(17):629-34. PubMed ID: 10829301
[TBL] [Abstract][Full Text] [Related]
17. Orlistat.
Wong NN; Cheng-Lai A
Heart Dis; 2000; 2(2):174-81. PubMed ID: 11728255
[TBL] [Abstract][Full Text] [Related]
18. [Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients].
Sjostrom L; Rissanen A; Andersen T; Boldrin M; Golay A; Koppeschaar H; Krempf M;
Ter Arkh; 2000; 72(8):50-4. PubMed ID: 11019429
[TBL] [Abstract][Full Text] [Related]
19. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women.
Bougoulia M; Triantos A; Koliakos G
Hormones (Athens); 2006; 5(4):259-69. PubMed ID: 17178701
[TBL] [Abstract][Full Text] [Related]
20. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials.
Hutton B; Fergusson D
Am J Clin Nutr; 2004 Dec; 80(6):1461-8. PubMed ID: 15585756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
